课题基金 / 基金详情

TAR-regulated reverse transcripition in HIV-1.

TAR-regulated reverse transcripition in HIV-1.
HIV-1 中 TAR 调节的逆转录。
批准号:
nhmrc : 290260
负责人:
A/Pr David Harrich
金额:
$16.95万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-01-01 至 2006-12-31

项目摘要

项目成果

A/Pr David Harrich的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
During reverse transcription, the positive-strand HIV-1 RNA genome is converted into a double-stranded DNA copy which can be permanently insert into the host cell genome. Our laboratory and others have shown that reverse transcription requires a complex array of molecules, which includes the viral RNA. These RNA can be organised into elaborate structures that have only been partially defined. Genetic experiments have revealed that one of these RNA structures, called TAR, is required for optimal initiation of reverse transcription (the first step of reverse transcription), but the precise mechanism is unknown. Recent advances in our laboratory have enabled a comprehensive study of the role played by TAR RNA in reverse transcription. Our leading hypotheses regarding the mechanism is required that TAR interacts with other RNA sequences or Reverse transcriptase in the initiation complex so that the reaction is optimal. This proposal will investigate these two leading hypotheses. Given the enormity of the HIV pandemic and the many recent reports from the United States that most patient isolated virus is resistant to at least one antiretroviral drug, these studies have as an outcome the identification and characterisation of important new key molecules towards which antiretroviral strategies can be designed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A potent anti-HIV-1 gene therapy agent in a humanised mouse model
A potent anti-HIV-1 gene therapy agent in a humanised mouse model
  • 批准号:
    nhmrc : GNT1085359
  • 项目类别:
    Project Grants
  • 资助金额:
    $110.11万
  • 财政年份:
    2015
  • 负责人:
    A/Pr David Harrich
  • 依托单位:
eEF1A1 is critical for HIV-1 reverse transcription and replication
The Human Eukaryotic Translation Elongation Factor 1A is a Paramyxovirus Virus Dependency Factor
国内基金
海外基金
Myostatin调控的miRNAs在骨骼肌发育中的功能及表达调控的分子机制
Myostatin调节的miRNAs基因在骨骼肌发育和肌干细胞激活中的表观遗传调控
Dyrk1A调控CaMKⅡδ的可变剪接及其在心脏重构过程中的作用
  • 批准号:
    30971223
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2009
  • 负责人:
    朱健华
  • 依托单位:
Cart基因保护缺血性脑损害及其分子机制的研究
  • 批准号:
    30470612
  • 项目类别:
    面上项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2004
  • 负责人:
    徐运
  • 依托单位: